Climacteric symptoms and control of the cycle in women aged 35 years or older taking an oral contraceptive with 0.150 mg desogestrel and 0.020 mg ethinylestradiol
- 31 January 1995
- journal article
- clinical trial
- Published by Elsevier in Contraception
- Vol. 51 (1), 13-18
- https://doi.org/10.1016/0010-7824(94)00009-l
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroidAmerican Journal of Obstetrics and Gynecology, 1990
- German Trial of an Oral Contraceptive Containing 0.150 mg Desogestrel Plus 0.020 mg EthinylestradiolActa Obstetricia et Gynecologica Scandinavica, 1987
- Belgian Trial of an Oral Contraceptive Containing 0.150 mg Desogestrel and 0.020 mg EthinylestradiolActa Obstetricia et Gynecologica Scandinavica, 1987
- A Clinical Comparison in Finland of Two Oral Contraceptives Containing 0.150 mg Desogestrel in Combination with 0.020 mg Or 0.030 mg EthinylestradiolActa Obstetricia et Gynecologica Scandinavica, 1987
- Evaluation of an Oral Contraceptive Containing 0.150 mg Desogestrel and 0.020 mg Ethinylestradiol in Women Aged 30 Years or OlderActa Obstetricia et Gynecologica Scandinavica, 1987
- Oral contraceptives and blood coagulation: A critical reviewAmerican Journal of Obstetrics and Gynecology, 1982
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations.BMJ, 1980
- THROMBOSIS WITH LOW-ESTROGEN ORAL CONTRACEPTIVESAmerican Journal of Epidemiology, 1975